| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Garfield Alastair is a Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $303K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 1,319 | $64.81 | $85,483.13 | -17.4% | +50.9% | - |